"DRESSed" to kill: Fatal case report of drug rash with eosinophilia and systemic symptoms
1
Department of Internal Medicine, Rijnstate Hospital, Arnhem, Netherlands
2
Department of Dermatology, Rijnstate Hospital, Arnhem, Netherlands
3
Department of Pathology, Rijnstate Hospital, Arnhem, Netherlands
Abstract
Multiorgan dysfunction syndrome (MODS) is a frequently encountered complication in patients who are admitted to the Intensive Care Unit with severe sepsis. Infrequently the same clinical syndrome can be caused by another pathophysiologic mechanism. We present a patient with possible Drug Rash, Eosinophilia and Systemic Symptoms (DRESS). This rare syndrome is caused by an allergic reaction to drugs. Treatment consists of discontinuation of the drug and supportive treatment. Early recognition of DRESS is vital to enable initiation of treatment at an early stage. Copyright © 2012, Nederlandse Vereniging voor Intensive Care. All Rights Reserved.
License
Copyright (c) Netharland Journal of Critical Care
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
Neth. J. Crit. Care open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.